These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 39234236

  • 1. Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.
    Akimova T, Wang L, Bartosh Z, Christensen LM, Eruslanov E, Singhal S, Aishwarya V, Hancock WW.
    Front Immunol; 2024; 15():1426657. PubMed ID: 39234236
    [Abstract] [Full Text] [Related]

  • 2. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.
    Revenko A, Carnevalli LS, Sinclair C, Johnson B, Peter A, Taylor M, Hettrick L, Chapman M, Klein S, Solanki A, Gattis D, Watt A, Hughes AM, Magiera L, Kar G, Ireland L, Mele DA, Sah V, Singh M, Walton J, Mairesse M, King M, Edbrooke M, Lyne P, Barry ST, Fawell S, Goldberg FW, MacLeod AR.
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387780
    [Abstract] [Full Text] [Related]

  • 3. Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii.
    Batista-Duharte A, Sendra L, Herrero MJ, Portuondo DL, Téllez-Martínez D, Olivera G, Fernández-Delgado M, Javega B, Herrera G, Martínez A, Costa PI, Zeppone Carlos I, Aliño SF.
    Int J Mol Sci; 2021 Mar 27; 22(7):. PubMed ID: 33801683
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
    Jung K, Kim JA, Kim YJ, Lee HW, Kim CH, Haam S, Kim YS.
    Cancer Immunol Res; 2020 Jan 27; 8(1):46-56. PubMed ID: 31554638
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25-Foxp3+ T cells.
    Polanczyk MJ, Walker E, Haley D, Guerrouahen BS, Akporiaye ET.
    J Transl Med; 2019 Jul 09; 17(1):219. PubMed ID: 31288845
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD, Mao YQ, Zhu LJ, Li J, Xie Y, Wang L, Zhang GB.
    Chin Med J (Engl); 2012 Jun 09; 125(11):2004-11. PubMed ID: 22884069
    [Abstract] [Full Text] [Related]

  • 11. Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade.
    Dixon ML, Luo L, Ghosh S, Grimes JM, Leavenworth JD, Leavenworth JW.
    Mol Cancer; 2021 Nov 20; 20(1):150. PubMed ID: 34798898
    [Abstract] [Full Text] [Related]

  • 12. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
    Kashyap AS, Thelemann T, Klar R, Kallert SM, Festag J, Buchi M, Hinterwimmer L, Schell M, Michel S, Jaschinski F, Zippelius A.
    J Immunother Cancer; 2019 Mar 12; 7(1):67. PubMed ID: 30871609
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Lozano T, Villanueva L, Durántez M, Gorraiz M, Ruiz M, Belsúe V, Riezu-Boj JI, Hervás-Stubbs S, Oyarzábal J, Bandukwala H, Lourenço AR, Coffer PJ, Sarobe P, Prieto J, Casares N, Lasarte JJ.
    J Immunol; 2015 Oct 01; 195(7):3180-9. PubMed ID: 26324768
    [Abstract] [Full Text] [Related]

  • 14. Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.
    Coe D, Begom S, Addey C, White M, Dyson J, Chai JG.
    Cancer Immunol Immunother; 2010 Sep 01; 59(9):1367-77. PubMed ID: 20480365
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA-126 regulates the induction and function of CD4(+) Foxp3(+) regulatory T cells through PI3K/AKT pathway.
    Qin A, Wen Z, Zhou Y, Li Y, Li Y, Luo J, Ren T, Xu L.
    J Cell Mol Med; 2013 Feb 01; 17(2):252-64. PubMed ID: 23301798
    [Abstract] [Full Text] [Related]

  • 18. Human LAP+GARP+FOXP3+ regulatory T cells attenuate xenogeneic graft versus host disease.
    Wang H, Song H, Pham AV, Cooper LJ, Schulze JJ, Olek S, Tran DQ.
    Theranostics; 2019 Feb 01; 9(8):2315-2324. PubMed ID: 31149046
    [Abstract] [Full Text] [Related]

  • 19. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4+ CD25high FOXP3+ Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor Recognition.
    Moorman CD, Curtis AD, Bastian AG, Elliott SE, Mannie MD.
    Front Immunol; 2018 Feb 01; 9():3119. PubMed ID: 30687323
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.